Vertex Pharmaceuticals Incorporated VRTX NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

84/100

5/7 Pass

SharesGrow Intrinsic Value

कुल 50 हाल के अंदरूनी लेनदेन दर्ज हैं Vertex Pharmaceuticals Incorporated (VRTX), जिसमें शामिल हैं 1 खरीद और 48 बिक्री. कुल अंदरूनी खरीद मूल्य RSU पुरस्कार और कुल अंदरूनी बिक्री मूल्य $50.44M.

हाल की गतिविधि वाले उल्लेखनीय अंदरूनी लोगों में शामिल हैं Liu Joy, Bozic Carmen, Mckechnie Duncan. अंदरूनी लेनदेन से पता चल सकता है कि कंपनी का नेतृत्व स्टॉक के मूल्यांकन और भविष्य की संभावनाओं को कैसे देखता है.

इनसाइडर ट्रेडिंग — VRTX

तिथि	नाम	भूमिका	लेनदेन प्रकार	शेयर	औसत मूल्य	मूल्य	स्वामित्व वाले शेयर
2026-04-01	Liu Joy	EVP and Chief Legal Officer	सूचित बिक्री	978	$449.17	$439.29K	21,833
2026-03-27	Bozic Carmen	EVP and CMO	सूचित बिक्री	2,329	$450.95	$1.05M	33,076
2026-03-13	Bozic Carmen	EVP and CMO	सूचित बिक्री	2,329	$481.79	$1.12M	35,405
2026-03-11	Mckechnie Duncan	EVP, Chief Commercial Officer	सूचित बिक्री	2,633	$498.42	$1.31M	12,489
2026-03-04	Mckechnie Duncan	EVP, Chief Commercial Officer	सूचित बिक्री	2,437	$475.30	$1.16M	15,122
2026-03-02	Liu Joy	EVP and Chief Legal Officer	सूचित बिक्री	892	$495.96	$442.4K	22,811
2026-03-01	Liu Joy	EVP and Chief Legal Officer	अज्ञात	7,044	$155.57	$1.1M	-
2026-02-27	Kewalramani Reshma	CEO & President	सूचित बिक्री	1,725	$496.95	$857.24K	98,278
2026-02-27	Bozic Carmen	EVP and CMO	सूचित बिक्री	2,329	$480.31	$1.12M	37,734
2026-02-26	Ambrose Kristen	SVP & Chief Accounting Officer	सूचित बिक्री	357	$483.36	$172.56K	6,624
2026-02-25	Sachdev Amit	EVP Chief Patient & Ext Af Off	सूचित बिक्री	1,846	$486.35	$897.8K	55,570
2026-02-25	Biller Jonathan	EVP and Chief Legal Officer	सूचित बिक्री	945	$486.35	$459.6K	13,659
2026-02-25	Tatsis Ourania	EVP, Chief Reg. & Quality Off.	सूचित बिक्री	260	$486.35	$126.45K	46,763
2026-02-25	Ambrose Kristen	SVP & Chief Accounting Officer	सूचित बिक्री	223	$486.35	$108.46K	6,981
2026-02-25	Atkinson Edward Morrow Iii	EVP, Chief Technical Ops. Off.	सूचित बिक्री	668	$486.35	$324.88K	18,432
2026-02-25	Mckechnie Duncan	EVP, Chief Commercial Officer	सूचित बिक्री	2,410	$489.00	$1.18M	17,559
2026-02-25	Bunnage Mark E.	EVP, Chief Scientific Officer	सूचित बिक्री	620	$486.35	$301.54K	7,284
2026-02-24	Wagner Charles F Jr	EVP, Co & Fo	RSU कर रोक	1,744	$485.11	$846.03K	47,042
2026-02-24	Leiden Jeffrey M	Executive Chairman	RSU कर रोक	3,547	$485.11	$1.72M	34,797
2026-02-24	Sachdev Amit	EVP Chief Patient & Ext Af Off	RSU कर रोक	1,518	$485.11	$736.4K	57,416
2026-02-24	Kewalramani Reshma	CEO & President	RSU कर रोक	4,981	$485.11	$2.42M	138,278
2026-02-24	Biller Jonathan	EVP and Chief Legal Officer	RSU कर रोक	1,144	$485.11	$554.97K	14,604
2026-02-24	Tatsis Ourania	EVP, Chief Reg. & Quality Off.	RSU कर रोक	1,627	$485.11	$789.27K	47,023
2026-02-24	Bozic Carmen	EVP and CMO	RSU कर रोक	1,453	$485.11	$704.86K	40,063
2026-02-24	Ambrose Kristen	SVP & Chief Accounting Officer	RSU कर रोक	546	$485.11	$264.87K	7,204
2026-02-24	Atkinson Edward Morrow Iii	EVP, Chief Technical Ops. Off.	RSU कर रोक	1,627	$485.11	$789.27K	19,100
2026-02-24	Mckechnie Duncan	EVP, Chief Commercial Officer	RSU कर रोक	873	$485.11	$423.5K	22,469
2026-02-24	Bunnage Mark E.	EVP, Chief Scientific Officer	RSU कर रोक	582	$485.11	$282.33K	7,904
2026-02-19	Sachdev Amit	EVP Chief Patient & Ext Af Off	विकल्प प्रयोग (बिक्री)	25,026	$187.53	$4.69M	-
2026-02-18	Leiden Jeffrey M	Executive Chairman	RSU कर रोक	2,964	$483.75	$1.43M	38,344
2026-02-18	Biller Jonathan	EVP and Chief Legal Officer	सूचित बिक्री	1,244	$473.68	$589.26K	15,748
2026-02-18	Tatsis Ourania	EVP, Chief Reg. & Quality Off.	सूचित बिक्री	368	$473.68	$174.31K	48,650
2026-02-18	Ambrose Kristen	SVP & Chief Accounting Officer	सूचित बिक्री	638	$473.68	$302.21K	7,750
2026-02-18	Atkinson Edward Morrow Iii	EVP, Chief Technical Ops. Off.	सूचित बिक्री	817	$473.68	$387K	20,727
2026-02-18	Bunnage Mark E.	EVP, Chief Scientific Officer	सूचित बिक्री	1,182	$473.68	$559.89K	8,486
2026-02-17	Wagner Charles F Jr	EVP, Co & Fo	RSU कर रोक	2,294	$483.75	$1.11M	48,786
2026-02-17	Leiden Jeffrey M	Executive Chairman	RSU पुरस्कार	8,269	-	-	41,308
2026-02-17	Sachdev Amit	EVP Chief Patient & Ext Af Off	RSU कर रोक	2,140	$483.75	$1.04M	69,042
2026-02-17	Kewalramani Reshma	CEO & President	RSU कर रोक	6,554	$483.75	$3.17M	143,259
2026-02-17	Biller Jonathan	EVP and Chief Legal Officer	सूचित बिक्री	2,476	$489.46	$1.21M	16,992
2026-02-17	Tatsis Ourania	EVP, Chief Reg. & Quality Off.	सूचित बिक्री	609	$489.46	$298.08K	49,018
2026-02-17	Bozic Carmen	EVP and CMO	RSU कर रोक	1,912	$483.75	$924.93K	41,516
2026-02-17	Ambrose Kristen	SVP & Chief Accounting Officer	सूचित बिक्री	1,557	$489.46	$762.09K	8,388
2026-02-17	Atkinson Edward Morrow Iii	EVP, Chief Technical Ops. Off.	सूचित बिक्री	2,031	$489.46	$994.09K	21,544
2026-02-17	Mckechnie Duncan	EVP, Chief Commercial Officer	RSU कर रोक	1,148	$483.75	$555.35K	23,342
2026-02-17	Bunnage Mark E.	EVP, Chief Scientific Officer	सूचित बिक्री	2,437	$489.46	$1.19M	9,668
2026-02-13	Wagner Charles F Jr	EVP, Co & Fo	RSU कर रोक	4,565	$487.76	$2.23M	43,715
2026-02-13	Sachdev Amit	EVP Chief Patient & Ext Af Off	RSU कर रोक	3,548	$487.76	$1.73M	65,393
2026-02-13	Bhatia Sangeeta N.	Director	सूचित बिक्री	266	$500.00	$133K	4,299
2026-02-13	Kewalramani Reshma	CEO & President	RSU कर रोक	13,041	$487.76	$6.36M	133,487

■ जानकारीपूर्ण — खुले बाजार में खरीद/बिक्री (सर्वाधिक महत्वपूर्ण) ■ गैर-जानकारी खरीद — पुरस्कार, विकल्प अभ्यास, रूपांतरण ■ गैर-जानकारी बिक्री — कर रोक, पुरस्कार बिक्री ■ तटस्थ — उपहार, ट्रस्ट, समाप्ति